CZ-backed YZi Labs escalates fight over CEA’s ‘poison pill’ and BNB treasury strategy
I'm PortAI, I can summarize articles.
Changpeng Zhao-backed YZi Labs is intensifying its opposition to CEA Industries over a newly adopted poison pill and bylaw amendments, claiming they are detrimental to shareholders and aimed at entrenching the current board. YZi has filed objections with the SEC and is pursuing a consent solicitation to expand CEA's board. The firm also disputes CEA's claims regarding its digital asset treasury strategy, citing comments from CEA's CEO about considering alternative tokens. CEA maintains its commitment to its BNB strategy and has not publicly addressed YZi's latest claims.
Source: Cointelegraph The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments